Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]

Haematology updates from SIOG 2020

Dr Tanya Wildes - SIOG Science & Education Committee Chair

Haematology updates from SIOG 2020 ( Dr Tanya Wildes - SIOG Science & Education Committee Chair )

The Burkitt lymphoma international prognostic index

Prof Adam Olszewski - Brown University, Providence, USA

The Burkitt lymphoma international prognostic index ( Prof Adam Olszewski - Brown University, Providence, USA )

OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma

Dr Dizon, Dr Trent, Dr Cordoba, Dr Rolfo, Dr Haanen

OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma ( Dr Dizon, Dr Trent, Dr Cordoba, Dr Rolfo, Dr Haanen )

Results of venetoclax and azacitidine combination in chemotherapy ineligible...

Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA

Results of venetoclax and azacitidine combination in chemotherapy ineligible untreated patients with AML ( Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA )

Long-term follow-up of low-intensity chemotherapy with combination therapy for...

Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA

Long-term follow-up of low-intensity chemotherapy with combination therapy for r/r Ph- acute lymphoblastic leukaemia patients ( Prof Hagop Kantarjian - MD Anderson Cancer Center, Houston, USA )

Real-world evidence of the use of carfilzomib among multiple myeloma patients...

Prof Evangelos Terpos - University of Athens, Athens, Greece

Real-world evidence of the use of carfilzomib among multiple myeloma patients across 10 European countries and Israel ( Prof Evangelos Terpos - University of Athens, Athens, Greece )

Real-world evidence of the use of carfilzomib to refractory to lenalidomide...

Prof Evangelos Terpos - University of Athens, Athens, Greece

$Real-world evidence of the use of carfilzomib to refractory to lenalidomide patients ( Prof Evangelos Terpos - University of Athens, Athens, Greece )$

A treatment comparison of carfilzomib, dexamethasone and daratumumab to...

Prof Evangelos Terpos - University of Athens, Athens, Greece

A treatment comparison of carfilzomib, dexamethasone and daratumumab to daratumumab and bortezomib ( Prof Evangelos Terpos - University of Athens, Athens, Greece )

PRWCC: Disease burden impacts outcomes in paediatric and young adult B-Cell ALL...

Dr Liora Schultz - Stanford University School of Medicine, Palo Alto, USA

PRWCC: Disease burden impacts outcomes in paediatric and young adult B-Cell ALL after commercial tisagenlecleucel ( Dr Liora Schultz - Stanford University School of Medicine, Palo Alto, USA )

Researchers trace the origin of blood cancer to early childhood, decades before...

Dr Jyoti Nangalia - University of Cambridge, Cambridge, UK

Researchers trace the origin of blood cancer to early childhood, decades before diagnosis ( Dr Jyoti Nangalia - University of Cambridge, Cambridge, UK )

Risk profiling of relapsed/refractory diffuse large B-cell lymphoma patients by...

Dr Alex Herrera - City of Hope Comprehensive Cancer Center, Duarte, USA

$Risk profiling of relapsed/refractory diffuse large B-cell lymphoma patients by measuring circulating tumour DNA ( Dr Alex Herrera - City of Hope Comprehensive Cancer Center, Duarte, USA )$

ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma

Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr...

$ASH 2020: Immunotherapy in relapsed/refractory multiple myeloma ( Dr Robert Rifkin, Prof Sagar Lonial, Prof Evangelos Terpos, Dr Nina Shah, Dr Eric Smith )$

More from ecancer